Wang, Wen <br/><br/>
Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study.  [electronic resource] 

 -  Expert opinion on drug safety  Mar 2020 
 - 339-347 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1744-764X 
<br/><br/><label>Standard No.: </label>10.1080/14740338.2020.1713090  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Bacterial Agents--adverse effects<br/>Blood Coagulation Disorders--chemically induced<br/>Blood Platelets--drug effects<br/>Cefoperazone--adverse effects<br/>Ceftazidime--adverse effects<br/>Drug Therapy, Combination--adverse effects<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Prothrombin Time--statistics & numerical data<br/>Sulbactam--adverse effects<br/>Tazobactam--adverse effects<br/>Young Adult